Latest California Healthline Stories
Watch: Rulings on Abortion Pill Have Far-Reaching Repercussions
Sarah Varney, a senior correspondent for KHN, joins Ali Rogin of PBS NewsHour to discuss the ruling by a federal judge in Texas that threatens nationwide access to the widely used abortion drug mifepristone, and a separate ruling in Washington state that reached the opposite conclusion.
Sen. Sanders Shows Fire, but Seeks Modest Goals, in His Debut Drug Hearing as Health Chair
The Vermont independent and former presidential candidate was all fire and brimstone at his first hearing on drug prices as head of the Senate HELP Committee. He also pursued a more modest goal of covid vaccine price reductions. It isn’t clear whether Sanders will succeed in even that, but he has put affordability front and center.
Judge Signals He Could Rule to Halt Sales of Common Abortion Pill
A U.S. District Court case is being widely followed because the judge’s decision could overturn the FDA’s approval of mifepristone two decades ago. With abortion rights polling well even in red states, anti-abortion activists are increasingly turning to the courts to achieve their aims.
Girls in Texas Could Get Birth Control at Federal Clinics, Until a Christian Father Objected
A Donald Trump-appointed federal judge agreed that even the possibility that the father’s daughters might access contraception without his permission violated the tenants of his Christian faith.
Watch: Emergency Room Turns Simple Injury Into a Big Bill
This installment of InvestigateTV and KHN’s “Costly Care” series looks at the case of a New Orleans woman whose thumb injury saddled her with a big ER bill for a tetanus shot and some minor care.
Watch: Walgreens Won’t Sell Abortion Pill in 21 States Under GOP Threat of Legal Action
Under pressure from Republican attorneys general, the nation’s second-largest pharmacy chain says it will not dispense the abortion pill mifepristone.
One Texas Judge Will Decide Fate of Abortion Pill Used by Millions of American Women
“What happens in Texas doesn’t stay in Texas,” warns an abortion rights advocate bracing for a district judge’s ruling on whether the abortion pill mifepristone was properly authorized by the FDA. His decision could force the medication off the U.S. market.
Watch: In Insurers’ Eyes, Not All Midwives Are Equal
The first installment of InvestigateTV and KHN’s “Costly Care” series explores one California mother’s experience struggling to get reimbursed for midwifery care and the differences between providers that may determine whether insurance covers them.
Watch: Covid Increases Risk of Heart Problems, New Data Underlines
Céline Gounder, KHN editor-at-large for public health, discusses new data showing an excess of deaths in 2020 related to heart disease.
Watch: Fifty Years after ‘Roe,’ Abortion Rights Battle Shifts to the States
On the 50th anniversary of Roe v. Wade, we asked people across the U.S. what the abrupt upending of abortion rights has meant to them, and we lay out the stakes in the battles ahead.